You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

CAFFEINE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Caffeine patents expire, and what generic alternatives are available?

Caffeine is a drug marketed by Am Regent, Eugia Pharma, Exela Pharma Science, Fresenius Kabi Usa, Micro Labs, Sagent Pharms, Sun Pharm, and Exela Pharma. and is included in thirteen NDAs.

The generic ingredient in CAFFEINE is caffeine citrate. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the caffeine citrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Caffeine

A generic version of CAFFEINE was approved as caffeine citrate by EXELA PHARMA SCIENCE on September 21^st, 2006.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CAFFEINE?
What are the global sales for CAFFEINE?
What is Average Wholesale Price for CAFFEINE?

Summary for CAFFEINE

US Patents:	0
Applicants:	8
NDAs:	13
Drug Prices:	Drug price information for CAFFEINE
DailyMed Link:	CAFFEINE at DailyMed

Drug patent expirations by year for CAFFEINE

Drug Prices for CAFFEINE

US Patents and Regulatory Information for CAFFEINE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Am Regent	CAFFEINE CITRATE	caffeine citrate	SOLUTION;INTRAVENOUS	077906-001	May 15, 2007	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sun Pharm	CAFFEINE CITRATE	caffeine citrate	SOLUTION;INTRAVENOUS	090077-001	Sep 30, 2009		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Fresenius Kabi Usa	CAFFEINE CITRATE	caffeine citrate	SOLUTION;INTRAVENOUS	077997-001	Jul 20, 2007	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sagent Pharms	CAFFEINE CITRATE	caffeine citrate	SOLUTION;ORAL	091102-001	Aug 29, 2012	AA	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for CAFFEINE

Has reducing caffeine intake helped lipitor cravings?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.